Surgeon-Delivered Nerve Block for Reduction of Perioperative Pain and Opioid Use After Lumbosacral Spine Surgery.
Ontology highlight
ABSTRACT:
SUBMITTER: Joiner EF
PROVIDER: S-EPMC9857272 | biostudies-literature | 2022 Dec
REPOSITORIES: biostudies-literature
Publications
Surgeon-Delivered Nerve Block for Reduction of Perioperative Pain and Opioid Use After Lumbosacral Spine Surgery.
Joiner Evan F EF Neira Justin A JA Yevudza Wisdom E WE Weller Mark A MA Wagener Gebhard G Angevine Peter D PD Mandigo Christopher E CE
JAMA network open 20221201 12
Similar Datasets
Project description:Perioperative pain control for hip arthroscopy procedures represents a significant challenge for both surgeons and anesthetists. In light of the opioid crisis, greater emphasis has been placed on multimodal pain control techniques. There is considerable debate regarding regional nerve blockade for hip arthroscopy. Although regional anesthesia has a significant role in perioperative pain management strategies, many of the most common techniques present their own risks and limitations. In particular, the less desirable effects of postoperative weakness in the lower extremity and difficulty with ambulation are commonly produced with standard regional blockades. We present a technique for performing a targeted, sensory nerve block that can be done efficiently and safely in the immediate preoperative period. This block can potentially lower the intraoperative and postoperative opioid requirements without the risks of muscle blockade and falls from other regional anesthesia modalities.
| S-EPMC8322623 | biostudies-literature
Project description:BackgroundPain management after anterior cruciate ligament reconstruction (ACLR) may pose a risk of prolonged opioid use.Questions/purposesThe purposes of this study in ACLR were to investigate the efficacy of a surgeon-administered local-regional block of specific genicular nerves on post-operative analgesia following ACLR and to quantify the outpatient opioid consumption and duration through the complete post-operative course.MethodsProspectively, all patients undergoing primary ACLR by a single surgeon were studied over a 10-month period. Exclusion criteria consisted of history of pre-operative opioid use, revision surgery, multi-ligament surgery, allergy to oral opioids, and allergy to local anesthetic. ACLR was performed using autograft or allograft patellar tendon bone (PTB) graft under general anesthesia. At the conclusion of the procedure, all patients received a local anesthetic (bupivacaine 0.25%) injection by the surgeon including a unique circumferential genicular nerve and fat pad block performed based on anatomic landmarks without use of image guidance. Post-operatively, the quantity and duration of opioid use (hydrocodone 5 mg) and pain scores were recorded for 4 months prospectively. Statistical analysis was performed to evaluate risk factors for increased opioid use.ResultsA single surgeon performed 75 ACLRs. After exclusions, a total of 70 patients were enrolled and followed prospectively. None were lost to follow-up. Total opioid consumption ranged from 0 to 30 tablets. The average number of opioid tablets used over the 4-month post-operative course was 5.5 (± 6.7). After surgery, 84% of patients took between 0 and 10 tablets and 21% of patients took no opioids throughout their entire post-operative course. The average duration of consumption was 2.6 days (± 3.1). No patients were taking opioids at the 6-week or 4-month follow-up. There were no refills required. No statistically significant differences were seen in regard to graft choice of autograft PTB (n = 48) vs allograft PTB (n = 22) in total opioid consumption or duration of use. In comparing adolescent (n = 31) versus adult (n = 39), no significant difference was seen in total opioid consumption or duration of use. All patients were satisfied with the post-operative pain management protocol.ConclusionOpioid use was unexpectedly low among patients undergoing ACLR after a surgeon-administered circumferential genicular nerve block and fat pad infiltration. With this protocol, the graft choice and patient age did not correlate with increased opioid use. These results could be useful in guiding post-operative opioid prescribing after ACLR.
| S-EPMC6384209 | biostudies-literature
Project description:BackgroundThe use of opioid analgesia is common in both the acute and extended post-operative periods after rotator cuff repair. The current opioid crisis has prompted surgeons to seek alternatives that minimize or even eliminate the need for oral opioids after surgery.Questions/purposesWe sought to investigate the effects on post-operative opioid use of a surgeon-administered block of the suprascapular and axillary nerves in arthroscopic rotator cuff repair (ARCR), in particular to quantify outpatient opioid consumption and duration.MethodsIn this prospective observational study, all patients undergoing primary ARCR performed under general anesthesia by a single surgeon were studied over a 15-month period. Of 91 ARCRs performed, 87 patients were enrolled and followed prospectively. At the conclusion of the procedure, the surgeon performed "local-regional" nerve blockade with injections to the sensory branches of the suprascapular nerve and the axillary nerve, as well as local infiltration about the shoulder. Use of medications in the post-anesthesia care unit was left up to the anesthesiologist. Patients were prescribed oral opioids (hydrocodone/acetaminophen 5/325 mg) for analgesia after discharge. The quantity and duration of opioid use and pain scores were recorded for 4 months. Statistical analysis was performed to evaluate factors that could account for greater opioid use.ResultsTotal opioid consumption ranged from 0 to 30 opioid tablets (average, 4.2 tablets) over the 4-month period. Post-operatively, 91% of patients took between ten or fewer tablets, and 39% took no opioids. The average duration of opioid use was 2.4 days. No patients were taking opioids at the 4- to 6-week or 4-month follow-up visits, none required refills, and none received prescriptions from outside prescribers. No statistically significant differences were seen in opioids taken or duration of use in regard to tear size, sex, body mass index, surgery location, or procedure time. There was a significant inverse correlation between opioid use and age. In addition, the cost of the surgeon-performed procedure was substantially lower than that associated with pre-operative nerve blockade performed by an anesthesiologist. All patients were satisfied with the post-operative pain management protocol. Average reported post-operative pain scores were low and decreased at each visit.ConclusionWith this local-regional nerve-blocking protocol, opioid use after ARCR was unexpectedly low, and a large proportion of patients recovered without any post-surgical opioids. The correlation seen between opioid use and age may not be clinically significant, given the low use of post-operative opioids overall. These results may be useful in guiding post-operative opioid prescribing after ARCR, as well as in lowering costs associated with ARCR.
| S-EPMC7749895 | biostudies-literature
Project description:Regional anesthetic blockade of the adductor canal following anterior cruciate ligament reconstruction has gained popularity due to theoretical benefit of improved patient experience, decreased requirement for pain medication and maintained motor function. However, this block does not cover the anterior and lateral genicular innervation to the knee, which may lead to persistent pain postoperatively. The following Technical Note details the genicular nervous system and provides rationale and technique for performing a simple surgeon-administered regional anesthetic at the completion of anterior cruciate ligament reconstruction to address the anterior and lateral genicular nervous system.
| S-EPMC8807714 | biostudies-literature
Project description:Lumbosacral (LS) stenosis is a cause of lower back pain, loss of mission readiness, and early retirement in military working dogs (MWDs). Aims of the present two-part study were to evaluate a sample of German Shepherd MWDs using standard clinical criteria for LS pain, standard qualitative computed tomographic (CT) criteria for LS stenosis, novel quantitative CT criteria for LS stenosis, and novel behavioral classification criteria for LS pain. Data were retrieved from archives of a tertiary referral MWD hospital. Study 1 was a retrospective, observational, two-group design with a hypothesis that there would be a significant difference in the percentage of affected German Shepherd MWDs with multilevel stenosis (affecting ≥ 3 vertebrae) between LS pain groups, based on standard clinical and qualitative CT criteria. Study 2 was a retrospective, observational, cross-sectional, two- and three-group study design with a hypothesis that quantitative CT measurements would significantly differ between LS pain groups, assigned based on 3 classification systems. The 1st classification system used standard clinical criteria, while the 2nd and 3rd novel classifications included behavioral signs of LS pain. The following quantitative CT measures were recorded without knowledge of behavioral classification: vertebral foramen area, vertebral foramen volume, vertebral foramen fat area; and ratios of vertebral foramen area/vertebral body area (foramen area ratio), cranial vertebral foramen area/caudal vertebral foramen area (cranial:caudal foramen area ratio), and vertebral fat area/vertebral body area (fat area ratio). Study 1 findings did not support the hypothesis in that there was no significant difference in the percentage of dogs affected with multilevel stenosis between LS pain groups (P = 0.6567). Findings for study 2 supported the hypothesis in that dogs with LS pain were significantly more affected by multilevel stenosis (P = 0.0273). Significant differences occurred between LS pain groups in select vertebral locations for all measurements (P ≤ 0.05) except vertebral foramen area and vertebral foramen volume (P > 0.05). Comparisons using novel quantitative CT measures and behavioral classification criteria identified significant differences between LS pain groups that were not detected using standard qualitative criteria. These novel quantitative and behavioral classification criteria may be helpful in future research on causes for early retirement in German Shepherd MWDs.
| S-EPMC7402633 | biostudies-literature
Project description:BackgroundReduction mammaplasty surgery is a commonly performed procedure in plastic surgery, offering significant improvements in quality of life. However, the postoperative period may be accompanied by considerable pain. In this study, we assess the impact of interpectoral block on reducing postoperative pain.MethodsThe study assessed postoperative pain using the Numeric Rating Scale at 3, 6, 12, and 24 hours following reduction mammaplasty surgery in a cohort of 46 patients operated on between January and September 2023. Among them, 28 patients received an interpectoral block, whereas 18 did not. Additionally, the study monitored analgesic intake, the incidence of shivering and nausea, and blood pressure and heart rate values in the postoperative period.ResultsIn patients undergoing interpectoral blockade, there was a statistically significant reduction in postoperative NRS values and the need for additional analgesic therapy. However, no significant differences were observed in the incidence of nausea and shivering between the 2 groups.ConclusionsThe implementation of pectoral nerve blocks appears to be a promising technique for mitigating postoperative pain in reduction mastopexy surgery.
| S-EPMC11658742 | biostudies-literature
Project description:IntroductionSpinal pain syndromes have a severe impact on the patient's sex life, contributing to a decrease in sexual function and sexual satisfaction. Despite the importance of sexual health on mental and physical wellbeing, sexual health is rarely discussed during consultations.Research questionThe aim of this study is to explore to what extent influencing factors can alter the discussion about sexual health during consultations. More specifically, we will evaluate the influence of healthcare profession, sex of the patient and the surgical approach that is proposed.Material and methodsAn online survey was sent to neurosurgeons, pain physicians and orthopedists in Belgium and The Netherlands in April 2019. Participants were asked about; counseling routine, knowledge, and opinion on sexual health. Answers were scored on a 5-point Likert scale. Independence between the response levels and type of surgery as well as profession were tested.ResultsIn total, 350 respondents were approached of whom 57 completed the survey. The majority of respondents (61.4%) indicated that they rarely or never discussed sexual disturbances. Profession and type of surgery had an influence on discussing erectile dysfunction, retrograde ejaculation, and alterations in orgasms. Thirty-five percent of healthcare providers considered it the patient's responsibility to bring up the subject of sexual health.Discussion and conclusionSexual health is rarely addressed by healthcare providers during spinal care. Profession as well as type of surgery seems to play a role on whether sexual health is discussed during consultations.
| S-EPMC10924173 | biostudies-literature
Project description:Opioid dependence is a national crisis, with 30 million patients annually at risk of becoming persistent opioid users after receiving opioids for post-surgical pain management. Translational Pain Services (TPS) demonstrate effectiveness for behavioral health improvements but its effectiveness in preventing persistent opioid use is less established, especially amongst opioid exposed patients. Prohibitive costs and accessibility challenges have hindered TPS program adoption. To address these limitations, we designed and implemented a remote telehealth TPS protocol focusing on preventing continued opioid use while improving behavioral health. Licensed therapists trained in the opioid-tapering CBT protocol delivered sessions reimbursed through standard payer reimbursement. Our prospective study evaluated the protocol's effectiveness on preventing persistent opioid use and behavioral health outcomes amongst both opioid naïve and exposed patients. In an opioid-naive patient cohort (n=67), 100% completely tapered off opioids, while in an opioid-exposed cohort (n =19) 52% completely tapered off opioids, demonstrating promising results. In both cohorts, we observed significant improvements in behavioral health scores, including pain. This opioid-tapering digital TPS is effective, adoptable, and incurs no out-of-pocket cost for healthcare systems. We provide the opioid-tapering CBT protocol in the supplement to facilitate adoption. Trial Registration Impact of Daily, Digital and Behavioral Tele-health Tapering Program for Perioperative Surgical Patients Exposed to Opioids and Benzodiazepines registered at clinicaltrials.gov, NCT04787692 . https://clinicaltrials.gov/ct2/show/NCT04787692?term=NCT04787692&draw=2&rank=1.
| S-EPMC10462235 | biostudies-literature
Project description:Pain is a frequent cause of physician visits. Many physicians find these patients challenging because they often have complicated histories, emotional comorbidities, confusing examinations, difficult problems to fix, and the possibility of factitious complaints for attention or narcotic pain medications. As a result, many patients are lumped into the category of chronic, centralized pain and relegated to pain management. However, recent literature suggests that surgical management of carefully diagnosed generators of pain can greatly reduce patients' pain and narcotic requirements. This article reviews recent literature on surgical management of pain and four specific sources of chronic pain amenable to surgical treatment: painful neuroma, nerve compression, myofascial/musculoskeletal pain, and complex regional pain syndrome type II.
| S-EPMC6361067 | biostudies-literature
Project description:BackgroundAs posterior lumbosacral spine fixation surgeries are common spine procedures done nowadays due to different causes and mostly accompanied with moderate-to-severe postoperative pain, so should find effective postoperative analgesia for these patients. This study aimed to observe analgesic effect of dexmedetomidine combined with bupivacaine versus bupivacaine alone for erector spinae plane block ESPB for postoperative pain control of posterior lumbosacral spine fixation surgeries.MethodsDouble-blind randomized controlled study including 90 patients who were randomly allocated into 3 groups (30 patients for each): Dexmedetomidine combined with bupivacaine (DB group), bupivacaine (B group), and saline (control) (S group). US-guided ESPB was performed preoperatively bilaterally in all patients of the 3 groups. All patients received intravenous patient-controlled postoperative analgesia with morphine and 1 gm intravenous paracetamol every 8 hours. Primary clinical outcomes were active (while mobilization) and passive (at rest) visual analog scale (VAS) pain score at first 24 hours measured every 2 hours, opioid consumption (number of PCA presses), and need for rescue analgesia. Other clinical outcomes included active and passive VAS pain score at second 24 hours, measured every 4 hours, opioid consumption, need for rescue analgesia, postoperative opioid side effects, and intraoperative dexmedetomidine side effects as bradycardia and hypotension.ResultsActive and passive VAS pain scores, postoperative opioid consumption, need for rescue analgesia, and postoperative opioid side effects were significantly lower in DB group when compared to other groups (B and S groups). There were no additional intraoperative dexmedetomidine side effects as bradycardia and hypotension. The estimated effect-size r was -0.58 and Cohen's d was -1.46.ConclusionAddition of dexmedetomidine to bupivacaine 0.25% in ESPB for postoperative pain control in patients of posterior lumbosacral spine fixation surgeries resulted in lower active and passive VAS pain scores, decreased postoperative opioid consumption, need for rescue analgesia and postoperative opioid side effects without additional intraoperative dexmedetomidine side effects.Clinicaltrialsgov identifierNCT05590234.
| S-EPMC10859055 | biostudies-literature